J-147
Tier C — Watch / tradeJ-147
Targets：MAOB
Indications (approved)：Ischaemic stroke, Alzheimer's disease
Regional status
Synthetic routes & intermediates1 routes
Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.
| Code | CAS No. | Intermediate |
|---|---|---|
| J-147-001 | 60480-83-3 | (2,4-dimethylphenyl)hydrazine hydrochloride |
| J-147-002 | 591-31-1 | 3-methoxybenzaldehyde |
| J-147-003 | 1400574-53-9 | (E)-1-(2,4-dimethylphenyl)-2-(3-methoxybenzylidene)hydrazine hydrochloride |
| J-147 | 1146963-51-0 | Acetic acid, 2,2,2-trifluoro-, 1-(2,4-dimethylphenyl)-2-[(3-methoxyphenyl)methylene]hydrazide |
Frequently asked questions
What are the approved indications of J-147?
Approved indications include: Ischaemic stroke, Alzheimer's disease.
When does the J-147 patent expire?
No public expiry year is available for J-147 yet; this page updates once verified.
How many synthesis routes are recorded for J-147?
1 synthesis routes are recorded; the shortest is 2 steps with 72.00% total yield. Intermediates in each route carry codes and CAS numbers.
Where can I buy J-147 intermediates?
All intermediates in J-147 routes have CAS profiles — you can submit an RFQ per CAS and it enters the Unibest matching pool.
How do I get a quote for J-147 intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-29